The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Health Review |
Texto Completo: | https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60625 |
Resumo: | Modern vaccines developed using mRNA technology are highly accurate formulations designed to stimulate the production of a variety of antigenic properties in the user in order to activate adaptive immunity. This enables the use of such technology in the research of vaccines against several infectious diseases, such as hepatitis C, Acquired Immunodeficiency Syndrome (AIDS), malaria, tuberculosis, in addition to chronic diseases, such as some types of cancer. Such vaccines were an efficient alternative in the fight against COVID-19 and have remarkable characteristics, such as the versatility of their applications and the ability to encode and express virtually any type of protein. Like this, this work is justified by the need to know the potential applications of this technology in clinical practice and in the search for effective alternative solutions in the fight against infectious and chronic diseases. A systematic review of the literature was carried out, including texts in Portuguese or English from 2019 to the present day and original texts published before 2019, searched in databases such as Science Direct, US National Library of Medicine, Scielo, Pubmed and Instituto Nacional de Industrial Property (INPI). |
id |
BJRH-0_8c5bd3408b146e3e9958000445398590 |
---|---|
oai_identifier_str |
oai:ojs2.ojs.brazilianjournals.com.br:article/60625 |
network_acronym_str |
BJRH-0 |
network_name_str |
Brazilian Journal of Health Review |
repository_id_str |
|
spelling |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatmentsmRNAvaccine technologyCOVID-19applicationsModern vaccines developed using mRNA technology are highly accurate formulations designed to stimulate the production of a variety of antigenic properties in the user in order to activate adaptive immunity. This enables the use of such technology in the research of vaccines against several infectious diseases, such as hepatitis C, Acquired Immunodeficiency Syndrome (AIDS), malaria, tuberculosis, in addition to chronic diseases, such as some types of cancer. Such vaccines were an efficient alternative in the fight against COVID-19 and have remarkable characteristics, such as the versatility of their applications and the ability to encode and express virtually any type of protein. Like this, this work is justified by the need to know the potential applications of this technology in clinical practice and in the search for effective alternative solutions in the fight against infectious and chronic diseases. A systematic review of the literature was carried out, including texts in Portuguese or English from 2019 to the present day and original texts published before 2019, searched in databases such as Science Direct, US National Library of Medicine, Scielo, Pubmed and Instituto Nacional de Industrial Property (INPI).Brazilian Journals Publicações de Periódicos e Editora Ltda.2023-06-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/6062510.34119/bjhrv6n3-318Brazilian Journal of Health Review; Vol. 6 No. 3 (2023); 12473-12492Brazilian Journal of Health Review; Vol. 6 Núm. 3 (2023); 12473-12492Brazilian Journal of Health Review; v. 6 n. 3 (2023); 12473-124922595-6825reponame:Brazilian Journal of Health Reviewinstname:Federação das Indústrias do Estado do Paraná (FIEP)instacron:BJRHenghttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60625/48096Silva, Ana Luiza Marques de Mirandade Araújo, Ana Paula SalesLima, Vitor Hugo Auzierde Oliveira, Ciane Martinsinfo:eu-repo/semantics/openAccess2024-02-26T20:11:12Zoai:ojs2.ojs.brazilianjournals.com.br:article/60625Revistahttp://www.brazilianjournals.com/index.php/BJHR/indexPRIhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/oai|| brazilianjhr@gmail.com2595-68252595-6825opendoar:2024-02-26T20:11:12Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP)false |
dc.title.none.fl_str_mv |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
title |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
spellingShingle |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments Silva, Ana Luiza Marques de Miranda mRNA vaccine technology COVID-19 applications |
title_short |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
title_full |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
title_fullStr |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
title_full_unstemmed |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
title_sort |
The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments |
author |
Silva, Ana Luiza Marques de Miranda |
author_facet |
Silva, Ana Luiza Marques de Miranda de Araújo, Ana Paula Sales Lima, Vitor Hugo Auzier de Oliveira, Ciane Martins |
author_role |
author |
author2 |
de Araújo, Ana Paula Sales Lima, Vitor Hugo Auzier de Oliveira, Ciane Martins |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Silva, Ana Luiza Marques de Miranda de Araújo, Ana Paula Sales Lima, Vitor Hugo Auzier de Oliveira, Ciane Martins |
dc.subject.por.fl_str_mv |
mRNA vaccine technology COVID-19 applications |
topic |
mRNA vaccine technology COVID-19 applications |
description |
Modern vaccines developed using mRNA technology are highly accurate formulations designed to stimulate the production of a variety of antigenic properties in the user in order to activate adaptive immunity. This enables the use of such technology in the research of vaccines against several infectious diseases, such as hepatitis C, Acquired Immunodeficiency Syndrome (AIDS), malaria, tuberculosis, in addition to chronic diseases, such as some types of cancer. Such vaccines were an efficient alternative in the fight against COVID-19 and have remarkable characteristics, such as the versatility of their applications and the ability to encode and express virtually any type of protein. Like this, this work is justified by the need to know the potential applications of this technology in clinical practice and in the search for effective alternative solutions in the fight against infectious and chronic diseases. A systematic review of the literature was carried out, including texts in Portuguese or English from 2019 to the present day and original texts published before 2019, searched in databases such as Science Direct, US National Library of Medicine, Scielo, Pubmed and Instituto Nacional de Industrial Property (INPI). |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60625 10.34119/bjhrv6n3-318 |
url |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60625 |
identifier_str_mv |
10.34119/bjhrv6n3-318 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60625/48096 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
dc.source.none.fl_str_mv |
Brazilian Journal of Health Review; Vol. 6 No. 3 (2023); 12473-12492 Brazilian Journal of Health Review; Vol. 6 Núm. 3 (2023); 12473-12492 Brazilian Journal of Health Review; v. 6 n. 3 (2023); 12473-12492 2595-6825 reponame:Brazilian Journal of Health Review instname:Federação das Indústrias do Estado do Paraná (FIEP) instacron:BJRH |
instname_str |
Federação das Indústrias do Estado do Paraná (FIEP) |
instacron_str |
BJRH |
institution |
BJRH |
reponame_str |
Brazilian Journal of Health Review |
collection |
Brazilian Journal of Health Review |
repository.name.fl_str_mv |
Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP) |
repository.mail.fl_str_mv |
|| brazilianjhr@gmail.com |
_version_ |
1797240030762106880 |